Dataset Information
A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma.
Ontology highlight
ABSTRACT:
SUBMITTER: Becker PS
PROVIDER: S-EPMC4916300 | biostudies-literature | 2016 May
REPOSITORIES: biostudies-literature